Recent Updates
Recently added Catalysts
MDXH Negative Sentiment Score: 40/100

MDxHealth SA and Subsidiaries UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS Three Months Ended March 31, In thousands of $ (except per share amounts) 2025 2024 Revenues $ 24,292 $ 19,834 Cost of sales (exc

Key Takeaway: MDxHealth SA reported their condensed consolidated financial results for the three months ending March 31, 2025. The company experienced a revenue increase to $24.29 million, up from $19.83 million in the same period the previous year. However, operating loss and total losses for the period both grew, with losses increasing to $9.21 million. Additionally, the company's total liabilities rose to approximately $168.87 million, reflecting increased financial obligations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Revenues increased from $19,834K to $24,292K.
  • Gross profit showed growth from $12,063K to $15,504K.
  • Cash and cash equivalents significantly rose to $65,672K.

CONCERNS & RISKS

  • Operating loss worsened from $6,604K to $4,588K.
  • Overall loss for the period increased to $9,209K from $8,511K.
  • Total liabilities increased from $142,488K to $168,865K.

Full Press Release Details

CONDENSED CONSOLIDATED STATEMENT OF PROFIT OR LOSS
Three Months Ended March 31,
In thousands of $ (except per share amounts) 2025 2024
Revenues $ 24,292 $ 19,834
Cost of sales (exclusive of amortization of intangible assets) (8,788 ) (7,771 )
Gross profit 15,504 12,063
Research and development expenses (2,499 ) (2,164 )
Selling and marketing expenses (9,821 ) (10,028 )
General and administrative expenses (5,842 ) (5,359 )
Amortization of intangible assets (1,322 ) (1,125 )
Other operating (expense) income, net (608 ) 9
Operating loss (4,588 ) (6,604 )
Financial income 692 1,371
Financial expenses (5,176 ) (3,278 )
Loss before income tax (9,072 ) (8,511 )
Income tax (137 ) -
Loss for the period $ (9,209 ) $ (8,511 )
Loss per share attributable to parent
Basic and diluted $ (0.19 ) $ (0.31 )
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
Thousands of $ March 31, 2025 December 31, 2024
ASSETS
Non-current assets
Goodwill $ 35,926 $ 35,926
Intangible assets 39,270 40,592
Property, plant and equipment 4,328 4,363
Right-of-use assets 8,199 8,617
Financial assets 777 936
Total non-current assets 88,500 90,434
Current assets
Inventories 3,326 3,869
Trade receivables 15,542 14,440
Prepaid expenses and other current assets 1,793 1,788
Cash and cash equivalents 65,672 46,798
Total current assets 86,333 66,895
TOTAL ASSETS $ 174,833 $ 157,329
EQUITY
Share capital $ 214,670 $ 214,670
Issuance premium 153,177 153,177
Accumulated deficit (378,724 ) (369,515 )
Share-based compensation 17,515 17,124
Translation reserve (670 ) (615 )
Total equity 5,968 14,841
LIABILITIES
Non-current liabilities
Loans and borrowings 75,368 50,967
Lease liabilities 7,056 7,413
Other non-current financial liabilities 43,281 41,445
Total non-current liabilities 125,705 99,825
Current liabilities
Loans and borrowings 162 324
Lease liabilities 1,392 1,360
Trade payables 7,552 8,001
Other current liabilities 6,474 6,567
Other current financial liabilities 27,580 26,411
Total current liabilities 43,160 42,663
Total liabilities 168,865 142,488
TOTAL EQUITY AND LIABILITIES $ 174,833 $ 157,329
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
Thousands of $ Three Months Ended March 31,
For the years ended December 31 2025 2024
CASH FLOWS FROM OPERATING ACTIVITIES
Operating loss $ (4,588 ) $ (6,604 )
Depreciation 925 775
Amortization of intangible assets 1,322 1,125
Share-based compensation 391 168
Other non-cash transactions 619 (1 )
Cash used in operations before working capital changes (1,331 ) (4,537 )
Decrease (+) / increase (-) in inventories 543 (265 )
Increase (-) in receivables (1,107 ) (1,392 )
Decrease (-) / increase (+) in payables (737 ) 679
Net cash outflow from operating activities (2,632 ) (5,515 )
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment (476 ) (220 )
Acquisition and generation of intangible assets - (544 )
Interests received 489 146
Net cash outflow from investing activities 13 (618 )
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from loan obligation, net of fees 24,250 -
Repayment of loan obligation (162 ) (160 )
Payment of lease liability (516 ) (475 )
Payment of interest (1,959 ) (947 )
Other financial expenses (127 ) (170 )
Net cash (outflow) / inflow from financing activities 21,486 (1,752 )
Net increase (+) / decrease (-) in cash and cash equivalents 18,867 (7,885 )
Cash and cash equivalents at beginning of period 46,798 22,380
Effect on exchange rate changes 7 (1 )
Cash and cash equivalents at end of period $ 65,672 $ 14,494

Frequently Asked Questions

What were the revenues for Q1 2025?

$24,292 thousand, up from $19,834 thousand in Q1 2024.

How much was the loss for the period in Q1 2025?

The loss for the period was $9,209 thousand.

What are the total current assets as of March 31, 2025?

Total current assets were $86,333 thousand.

What was the operating loss for Q1 2025?

The operating loss was $4,588 thousand.

How much cash was available at the end of Q1 2025?

Cash and cash equivalents at the end were $65,672 thousand.

Last updated: May 14, 2025